LinkMed: Likvor Receives an Order for CELDA(TM) from Uppsala University Hospital
Published: Dec 11, 2009
STOCKHOLM--(BUSINESS WIRE)--Regulatory News: LinkMed’s (STO:LMED) portfolio company Likvor has received an order for Likvor CELDA™ from Uppsala University Hospital (Akademiska Universitetssjukhuset). With Likvor CELDA™ the clinical will be able to dynamic measure the most important parameters concerning the patients’ cerebrospinal fluid including pressure and flow. Likvor CELDA™ was developed to facility greater understanding and enhancing diagnosis of normal pressure hydrocephalus (NPH), a condition that is often mistaken for dementia. This is the second order for the instrument; the fist came from Norrlands Universitetssjukhus, Umeå.